HomeCompareKSHB vs MRK

KSHB vs MRK: Dividend Comparison 2026

KSHB yields 287.77% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KSHB wins by $1146.41M in total portfolio value
10 years
KSHB
KSHB
● Live price
287.77%
Share price
$0.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1146.44M
Annual income
$680,953,564.37
Full KSHB calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — KSHB vs MRK

📍 KSHB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKSHBMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KSHB + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KSHB pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KSHB
Annual income on $10K today (after 15% tax)
$24,460.43/yr
After 10yr DRIP, annual income (after tax)
$578,810,529.71/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, KSHB beats the other by $578,809,721.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KSHB + MRK for your $10,000?

KSHB: 50%MRK: 50%
100% MRK50/50100% KSHB
Portfolio after 10yr
$573.24M
Annual income
$340,477,257.34/yr
Blended yield
59.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KSHB
Analyst Ratings
1
Buy
Consensus: Buy
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KSHB buys
0
MRK buys
0
No recent congressional trades found for KSHB or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKSHBMRK
Forward yield287.77%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$1146.44M$30.7K
Annual income after 10y$680,953,564.37$950.29
Total dividends collected$1099.12M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: KSHB vs MRK ($10,000, DRIP)

YearKSHB PortfolioKSHB Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$39,477$28,776.98$11,192$351.54+$28.3KKSHB
2$148,411$106,170.86$12,524$392.70+$135.9KKSHB
3$531,831$373,030.53$14,015$438.65+$517.8KKSHB
4$1,818,360$1,249,301.12$15,682$489.96+$1.80MKSHB
5$5,937,639$3,991,994.20$17,547$547.23+$5.92MKSHB
6$18,535,877$12,182,603.39$19,632$611.16+$18.52MKSHB
7$55,376,519$35,543,130.11$21,963$682.53+$55.35MKSHB
8$158,492,336$99,239,461.34$24,571$762.18+$158.47MKSHB
9$435,037,110$265,450,310.34$27,486$851.08+$435.01MKSHB
10$1,146,443,272$680,953,564.37$30,745$950.29+$1146.41MKSHB

KSHB vs MRK: Complete Analysis 2026

KSHBStock

KushCo Holdings, Inc. markets and sells packaging products, vaporizers, solvents, accessories, and branding solutions to customers operating in the regulated medical and adult recreational cannabis and hemp-derived cannabidiol (CBD) industries in the United States, Canada, and internationally. Its principal products include bottles, jars, bags, tubes, containers, vape cartridges, vape batteries and accessories, labels and processing supplies, solvents, natural products, stainless steel tanks, and custom branded anti-counterfeit and authentication labels. The company also offers hemp trading and retail services. The company sells products to the business-to-business market, which includes brand owners, farmers, growers, processors, producers, distributors, and licensed retailers in states with legal medical and/or adult recreational use cannabis programs and legal CBD programs through its direct sales force and e-commerce website. The company was formerly known as Kush Bottles, Inc. and changed its name to KushCo Holdings, Inc. in September 2018. KushCo Holdings, Inc. was founded in 2010 and is headquartered in Cypress, California.

Full KSHB Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this KSHB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KSHB vs SCHDKSHB vs JEPIKSHB vs OKSHB vs KOKSHB vs MAINKSHB vs JNJKSHB vs ABBVKSHB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.